Taysha Gene Therapies Inc...

NASDAQ: TSHA · Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.98
1.88%
After-hours: Aug 15, 2025, 07:17 PM EDT

Taysha Gene Therapies Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.85 -3.68 -2.39 -10
PEG Ratio
0.08 0.05 0.13 -0.11
PS Ratio
51.93 26.60 158.80 n/a
PB Ratio
6.05 5.49 418.68 18.39
P/FCF Ratio
-5.3 -5.11 -3.51 -12.66
P/OCF Ratio
-5.33 -5.63 -4.5 -14.99
OCF/S Ratio
-9.75 -4.73 -35.33 n/a
Debt / Equity Ratio
0.88 0.82 63.15 0.66
Quick Ratio
5.42 4.08 1.54 3.08
Current Ratio
5.42 4.08 1.54 3.08
Asset Turnover
0.05 0.09 0.02 n/a
Interest Coverage
-896.66 -14.49 -42.77 -121.34
Return on Equity
-1.25 -1.49 -174.94 -1.84
Return on Assets
-0.56 -0.65 -1.31 -0.82
Return on Invested Capital
-0.66 -0.52 -2.44 -1.07
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 n/a
Net Profit Margin
-10.72 -7.22 -66.35 n/a
Pretax Profit Margin
-10.72 -7.22 -66.35 n/a
Operating Profit Margin
-10.98 -4.69 -64.93 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-10.55 -6.81 -63.84 n/a